Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Receivables - Other: 2024

Historic Receivables - Other for Avidity Biosciences (RNA) over the last 1 years, with Dec 2024 value amounting to $9.4 million.

  • Avidity Biosciences' Receivables - Other was N/A to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year change of. This contributed to the annual value of $9.4 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Avidity Biosciences' Receivables - Other is $9.4 million.
  • In the past 5 years, Avidity Biosciences' Receivables - Other ranged from a high of $9.4 million in FY2024 and a low of $9.4 million during FY2024.
  • In the last 1 years, Avidity Biosciences' Receivables - Other had a median value of $9.4 million in 2024 and averaged $9.4 million.